JP2021510723A5 - - Google Patents
Info
- Publication number
- JP2021510723A5 JP2021510723A5 JP2020540345A JP2020540345A JP2021510723A5 JP 2021510723 A5 JP2021510723 A5 JP 2021510723A5 JP 2020540345 A JP2020540345 A JP 2020540345A JP 2020540345 A JP2020540345 A JP 2020540345A JP 2021510723 A5 JP2021510723 A5 JP 2021510723A5
- Authority
- JP
- Japan
- Prior art keywords
- powder
- shell
- composition according
- container
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862622464P | 2018-01-26 | 2018-01-26 | |
| US62/622,464 | 2018-01-26 | ||
| PCT/IB2019/050607 WO2019145897A1 (en) | 2018-01-26 | 2019-01-24 | High dose delivery of inhaled therapeutics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021510723A JP2021510723A (ja) | 2021-04-30 |
| JP2021510723A5 true JP2021510723A5 (enExample) | 2022-01-19 |
Family
ID=65635769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020540345A Pending JP2021510723A (ja) | 2018-01-26 | 2019-01-24 | 吸入型治療薬の高用量送達 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210069106A1 (enExample) |
| EP (1) | EP3743045A1 (enExample) |
| JP (1) | JP2021510723A (enExample) |
| KR (1) | KR20200115560A (enExample) |
| CN (1) | CN111526870A (enExample) |
| AR (1) | AR114308A1 (enExample) |
| AU (2) | AU2019212586C1 (enExample) |
| BR (1) | BR112020014793A2 (enExample) |
| CA (1) | CA3089439A1 (enExample) |
| CL (1) | CL2020001939A1 (enExample) |
| IL (1) | IL276241A (enExample) |
| MX (1) | MX2020007745A (enExample) |
| RU (1) | RU2020127882A (enExample) |
| WO (1) | WO2019145897A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022002980A (es) | 2019-09-16 | 2022-04-06 | Amgen Inc | Metodo para la esterilizacion externa de un dispositivo de suministro de farmacos. |
| UA129038C2 (uk) * | 2019-10-28 | 2024-12-25 | Медіммуне Лімітед | Сухий порошкоподібний склад антитіла, що зв'язує тимічний стромальний лімфопоетин (tslp) |
| WO2026082944A1 (en) | 2024-10-17 | 2026-04-23 | Hovione Farmaciência S.A. | High-density composite active particles comprising beta-lactoglobulin and api, compositions comprising same, and methods for the manufacture thereof |
| CN119306869B (zh) * | 2024-12-13 | 2025-05-16 | 万华化学集团股份有限公司 | 一种乙烯/α-烯烃共聚物及其制备方法、采用其的封装胶膜 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1992335A1 (en) | 2001-11-01 | 2008-11-19 | Nektar Therapeutics | Spray drying methods and compositions thereof |
| KR20050088243A (ko) | 2002-12-30 | 2005-09-02 | 넥타르 테라퓨틱스 | 프리필름화 분무기 |
| HUE025151T2 (en) * | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diceto-piperazine salts for drug delivery |
| US8900555B2 (en) * | 2006-07-27 | 2014-12-02 | Nektar Therapeutics | Insulin derivative formulations for pulmonary delivery |
| TR200907236A2 (tr) * | 2009-09-23 | 2011-04-21 | Bi̇lgi̇ç Mahmut | Tiotropyum kuru toz formülasyonunun blister ambalajda taşınması. |
| JOP20120023B1 (ar) * | 2011-02-04 | 2022-03-14 | Novartis Ag | صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية |
| US20150136130A1 (en) * | 2012-02-29 | 2015-05-21 | Pulmatrix, Inc. | Inhalable dry powders |
| US10577554B2 (en) * | 2013-03-15 | 2020-03-03 | Children's Medical Center Corporation | Gas-filled stabilized particles and methods of use |
| EA038332B1 (ru) * | 2015-09-09 | 2021-08-10 | Новартис Аг | Молекулы, связывающиеся с тимусным стромальным лимфопоэтином (tslp), и способы применения таких молекул |
| WO2017042696A1 (en) * | 2015-09-09 | 2017-03-16 | Novartis Ag | Targeted delivery of spray-dried formulations to the lungs |
| US10967139B2 (en) | 2016-01-19 | 2021-04-06 | Novartis Ag | Multidose inhaler |
| IL260823B2 (en) * | 2016-01-29 | 2024-08-01 | Mannkind Corp | Dry powder inhaler |
-
2019
- 2019-01-24 RU RU2020127882A patent/RU2020127882A/ru unknown
- 2019-01-24 AR ARP190100160A patent/AR114308A1/es not_active Application Discontinuation
- 2019-01-24 BR BR112020014793-1A patent/BR112020014793A2/pt not_active Application Discontinuation
- 2019-01-24 CN CN201980007046.7A patent/CN111526870A/zh active Pending
- 2019-01-24 MX MX2020007745A patent/MX2020007745A/es unknown
- 2019-01-24 AU AU2019212586A patent/AU2019212586C1/en not_active Ceased
- 2019-01-24 EP EP19708669.7A patent/EP3743045A1/en not_active Withdrawn
- 2019-01-24 CA CA3089439A patent/CA3089439A1/en active Pending
- 2019-01-24 JP JP2020540345A patent/JP2021510723A/ja active Pending
- 2019-01-24 KR KR1020207024324A patent/KR20200115560A/ko not_active Ceased
- 2019-01-24 WO PCT/IB2019/050607 patent/WO2019145897A1/en not_active Ceased
- 2019-01-24 US US16/963,678 patent/US20210069106A1/en not_active Abandoned
-
2020
- 2020-07-23 CL CL2020001939A patent/CL2020001939A1/es unknown
- 2020-07-23 IL IL276241A patent/IL276241A/en unknown
-
2022
- 2022-04-05 AU AU2022202278A patent/AU2022202278A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2025204271A1 (en) | Microcrystalline diketopiperazine compositions and methods | |
| JP6491658B2 (ja) | 熱安定性乾燥粉末医薬組成物及び方法 | |
| CN106163598B (zh) | 尼古丁粉末吸入器 | |
| AU2019282808B2 (en) | Composition and method for inhalation | |
| US6616914B2 (en) | Method for pulmonary and oral delivery of pharmaceuticals | |
| ES2880271T3 (es) | Polvos pulmonares de ultra baja densidad | |
| RO120532B1 (ro) | Dispozitiv şi metodă de eliberare modulată a agenţilor activi aerosoli | |
| CA2838030A1 (en) | Combination comprising umeclidinium and a corticosteroid | |
| Kaur et al. | Advanced aerosol delivery devices for potential cure of acute and chronic diseases | |
| RU2020127882A (ru) | Доставка высоких доз ингаляционных терапевтических средств | |
| US20190321290A1 (en) | Composition and method for inhalation | |
| US20250228779A1 (en) | Method and composition for treating pulmonary fibrosis | |
| RU2018112077A (ru) | Направленная доставка высушенных распылением композиций в легкие | |
| JP2025061049A (ja) | 吸入可能な乾燥粉末 | |
| Carvalho et al. | Dry powder inhalation for pulmonary delivery: recent advances and continuing challenges | |
| UA119774C2 (uk) | Комбінації формотеролу і будесоніду для лікування хронічної обструктивної хвороби легень (хохл) | |
| JP2007520507A5 (enExample) | ||
| IT202000005026A1 (it) | Lattoferrina per uso inalatorio ad azione antivirale | |
| JP2023524064A (ja) | ウイルス感染を治療又は予防するためのクロファジミン組成物及び方法 | |
| JP2022527054A5 (enExample) | ||
| Dongare et al. | An overview of recently published patents on pulmonary drug delivery devices | |
| AU2022376952A1 (en) | Methods and compositions for treating pulmonary hypertension | |
| SE527200C2 (sv) | Inhalatoranordning samt kombinerade doser av formaterol och fluticason | |
| EP2931252A1 (en) | Combination of umeclidinium, fluticasone propionate and salmeterol xinafoate for use in the treatment of inflammatory or respiratory tract diseases | |
| Vecellio et al. | Deposition in three nasal cast models with a new concept of nasal administration (Retronose) vs nasal spray |